Gene

MET - Renal cell carcinoma, papillary type 1

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 509

MET - Renal cell carcinoma, papillary type 1



€ 509

MET - Renal cell carcinoma, papillary type 1

This test is available for the following conditions:

  • Conditions > Renal / Nephrological > Renal cell carcinoma
  • Conditions > Oncogenetics > Renal cell carcinoma

This product is also part of the following panels:

  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • WES hearing impairment (99.3% **)
  • WES hereditary cancer (99.3% **)
  • WES Mendelian inherited disorders (99.3% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 164860
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509